Infection in xenotransplantation

Area of Science:

• Transplantation Immunology
• Infectious Diseases
• Microbiology

Background:

• Xenotransplantation is a potential solution for end-stage organ failure.
• Interspecies transplantation raises concerns about animal-derived pathogen transmission (xenosis).
• The immunocompromised state of recipients can alter pathogen behavior and complicate diagnosis.

Purpose of the Study:

• To explore the potential risks and benefits of xenotransplantation.
• To address concerns regarding xenosis and pathogen activation, particularly retroviruses.
• To outline the need for safety protocols in xenotransplantation.

Main Methods:

• Review of transplantation immunology advancements.
• Analysis of potential pathogen risks, including latent virus activation.
• Consideration of strategies for pathogen exclusion from donor animals.
• Evaluation of xenotransplantation for treating chronic infections.

Main Results:

• Xenotransplantation presents a viable therapeutic option for organ failure.
• Xenosis is a significant risk, potentially complicated by altered pathogen behavior in recipients.
• Latent viruses, such as retroviruses, pose a particular concern.
• Prospective pathogen exclusion from donor herds is feasible, drawing from allogeneic transplantation experience.

Conclusions:

• Further research into retroviral activation and pathogen behavior in xenotransplantation is essential.
• Xenotransplantation may offer therapeutic benefits beyond organ replacement, including treating chronic infections.
• Development of robust clinical protocols is critical to ensure recipient and public safety.